Search
Guardant Health Inc
GHAdd to Watchlist
131.780USD
+2.670+2.07%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
17.33BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Oncology
683.60M
69.61%
Biopharma and data
210.13M
21.40%
Screening
79.73M
8.12%
Licensing and other
8.56M
0.87%
By RegionUSD
Name
Revenue
Proportion
United States
923.28M
94.02%
International
58.74M
5.98%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Oncology
683.60M
69.61%
Biopharma and data
210.13M
21.40%
Screening
79.73M
8.12%
Licensing and other
8.56M
0.87%
